Treatment Registry

Company

LIV by WellNow

LIV by WellNow publishes compounded semaglutide at $195 a month — Average dose, monthly (regular price, medication included).

  • 1 program
  • 1 molecule
  • 1 reading

Read from liv.wellnow.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.

Go to LIV by WellNow

Visit LIV by WellNow

We earn nothing from this link. LIV by WellNow has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

What it costs

first month, including the required fees on record · Average dose, monthly (regular price, medication included)

Terms

StatesIllinois, Indiana, Michigan, New York, and Pennsylvania

Not yet checked: pharmacy, membership and consultation fee.

Terms can differ between this company’s programs; each entry carries its own.

Programs

EntryProviderPer month
at its shortest term
Link
TR-0414LIV by WellNow$195
Average dose, monthly (regular price, medication included)
Record

Notes

Recorded against this company rather than one program.

September 2, 2026

  1. 1. Company confirmed via own site (title, footer '© 2026 LIV by WellNow', and legal disclaimer naming 'LIV by WellNow' and its parent 'WellNow Urgent Care'). Sells GLP-1 compounded semaglutide only (no tirzepatide product found). The $195/mo (and $175/$249/$265 variants) figure is explicitly the FULL price including medication -- 'Membership includes medication, supplies and unlimited virtual visits' and 'The starting price for the average dose of compounded semaglutide is $195 per month — for everything' -- so these were recorded as prices, not membership, since medication is included rather than billed separately. Quarterly upfront totals ($525, $747) are arithmetic derived from the stated monthly-equivalent figures ($175 x 3, $249 x 3); the site states the discount is '$20/month discount from quarterly (3-month) all in one payment equals $60 total discount.' Neither vial nor pen is specified for the self-administered subcutaneous injection, so form is not-disclosed. Site does not mention tirzepatide/Zepbound/Mounjaro anywhere in pages checked.

Before you act

Cite this

Treatment Registry. (2026). LIV by WellNow: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/liv-by-wellnow